2020
A prospective multicenter study of laser ablation for drug resistant epilepsy – One year outcomes
Landazuri P, Shih J, Leuthardt E, Ben-Haim S, Neimat J, Tovar-Spinoza Z, Chiang V, Spencer D, Sun D, Fecci P, Baumgartner J. A prospective multicenter study of laser ablation for drug resistant epilepsy – One year outcomes. Epilepsy Research 2020, 167: 106473. PMID: 33045664, DOI: 10.1016/j.eplepsyres.2020.106473.Peer-Reviewed Original ResearchConceptsMesial temporal lobe epilepsyLaser interstitial thermal therapySeizure outcomeLife scoresPotential clinical characteristicsMulti-center registryDrug-resistant epilepsyProspective multicenter studyEffective treatment optionTemporal lobe epilepsyFocal cortical dysplasiaSocial functioning scoresInterstitial thermal therapyEngel IPain scoresAdverse eventsClinical characteristicsSeizure worryEpilepsy typeResistant epilepsySurgical treatmentShorter hospitalizationCortical dysplasiaHypothalamic hamartomaLobe epilepsy
2016
Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH, Dosoretz AP, Magnuson WJ, Laurans MS, Chiang VL, Yu JB. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases. Journal Of Neurosurgery 2016, 125: 18-25. PMID: 27903191, DOI: 10.3171/2016.7.gks161499.Peer-Reviewed Original ResearchConceptsWhole-brain radiation therapyIncremental cost-effectiveness ratioQuality-adjusted life yearsBrain metastasesStereotactic radiosurgeryProbabilistic sensitivity analysesJLGK0901 studyRadiation therapyEffective treatment optionMethods A Markov modelCost-effectiveness ratioHealth state utilitiesCost-effective relativeStandard gamble methodA Markov modelRecurrence ratePatient preferencesTreatment optionsPatientsMetastasisLife yearsEuropean OrganizationPay thresholdsEnd pointCost-effective strategy